The tiny worm that’s changing medicine

Adult C. elegans hermaphrodite. The red stain marks the sperm that are stored in an organ called the spermatheca. Image by Dr. Volker Nitschko.

Healthy aging, stress, neurodegenerative disorders, microRNA, cancer—it’s a long list of health research topics, and all of it starts with C. elegans, a tiny roundworm that is fundamental to the field of genetics.

Caenorhabditis elegans is a 1-mm long nematode that consists of 1,000 cells, with a simple nervous system and six sets of chromosomes. They live for about 30 days. The animal’s simplicity makes it a perfect organism for genetic research.

C. elegans is, in the words of geneticist Dr. Stefan Taubert, “a tool for discovery.” The Taubert lab at UBC’s Department of Medical Genetics, studies stress responses at the cellular level in C. elegans, mice, and cancer cells, including high and low temperatures, starvation, and low oxygen.

“We have specific questions that we ask, and we discover the answer in C. elegans before moving forward,” said Dr. Taubert. “The whole process of discovery begins in the more basic organisms like C. elegans and then it’s translated to mammals.”

Dr. Stefan Taubert and his lab group

University of Toronto researcher Dr. Julie Claycomb agrees with Dr. Taubert’ sentiment. She’s made a career out of studying these worms, although admits that she didn’t like them at first. “We are studying C. elegans to figure out how stuff works. It’s fundamental, discovery-based research with implications for human health two or three steps down the road,” says Dr. Claycomb.

That down-the-line research is starting to bear fruit, and has even led to Nobel Prizes. The 2024 Nobel Prize for Physiology or Medicine went to Victor Ambros and Gary Ruvkun for their discovery of microRNA using C. elegans as a model organism. Current research at Dr. Claycomb’s lab is also focused on microRNA using C. elegans to better understand processes related to gene expression and RNA interference.

Dr. Julie Claycomb

Small RNAs like microRNA are present in all human cells and will have a large impact on future health research, with C. elegans as a model. And the scientists who will make the next great discovery with C. elegans, whether on the topic of Huntington’s or healthy aging, toxicology or RNA transcription, are already being trained at Taubert’s and Claycomb’s labs.

C. elegans is a wonderful organism for training new scientists and teaching them how to do experiments,” says Dr. Claycomb, who has showed off the little nematodes to undergrads and her son’s kindergarten class. “They are a tangible, accessible platform to do genetics, molecular biology, and genomics.”

At a glance

Issue

Before a treatment is available for humans, research begins on model organisms, one of the most common being the nematode Caenorhabditis elegans. With 1,000 cells and basic organs, C. elegans is a great first specimen for genetic research.

Research

Countless projects begin with C. elegans, from research on cancer to neurodegenerative diseases, from pathogens to healthy aging. In Canada, researchers are currently using C. elegans to evaluate stress response at the cellular level, stop the growth of dangerous amyloid proteins, and make ground-breaking discoveries in the field of microRNA.

From lab bench to Nobel stage

C. elegans has been at the centre of work leading to four Nobel Prizes:

  1. 2002: For “discoveries concerning genetic regulation of organ development and programmed cell death.”
  2. 2006: For “the discovery of RNA interference-gene silencing by double-stranded RNA.”
  3. 2008: For “the discovery and development of the green fluorescent protein, GFP.”
  4. 2024: For “the discovery of microRNA and its role in post-transcriptional gene regulation.”
Date modified: